ConductScience.org, home

Paper17547312

Botulinum toxin type-a in the prevention of migraine: a double-blind controlled trial.

Vo AH and 6 others. Aviat Space Environ Med, 2007. Cited by 28 papers, by iCite.

Cite this record

ConductScience Library. Botulinum toxin type-a in the prevention of migraine: a double-blind controlled trial. Papers, record 17547312. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17547312

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Botulinum toxin type-a in the prevention of migraine: a double-blind controlled trial.
PubMed
Journal
Aviat Space Environ Med
PubMed
Year
2007
PubMed
Publication types
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
1.05
iCite
Revised in PubMed
2010-11-18
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vo AHAlexander H
2Satori RRoberto
3Jabbari BBahman
4Green JJody
5Killgore WDWilliam D S
6Labutta RRobert
7Campbell WWWilliam W

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Botulinum Toxins, Type AMajor topic
Migraine DisordersMajor topic
Neuromuscular AgentsMajor topic
Adolescent
Adult
Aged
Analysis of Variance
Chi-Square Distribution
Double-Blind Method
Female
Humans
Male
Middle Aged
Military Medicine
Treatment Outcome

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT01226706Efficacy of Botulinum Toxin Type A for the Treatment of Non-neurogenic Urinary Urge IncontinenceBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
39679425The Efficacy of Botulinum Toxin Use in Service Members and Veterans with Migraine and Post-Traumatic Headache Disorders: A Scoping Review.J Pain Res2024https://conductscience.org/library/papers/39679425PubMed
37235366Safety of Onabotulinumtoxin A in Chronic Migraine: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.Toxins (Basel)2023https://conductscience.org/library/papers/37235366PubMed
36136557Botulinum Toxin-A Current Place in the Treatment of Chronic Migraine and Other Primary Headaches.Toxins (Basel)2022https://conductscience.org/library/papers/36136557PubMed
31398813Botulinum Toxin a Valuable Prophylactic Agent for Migraines and a Possible Future Option for the Prevention of Hormonal Variations-Triggered Migraines.Toxins (Basel)2019https://conductscience.org/library/papers/31398813PubMed
31315864Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine.BMJ Open2019https://conductscience.org/library/papers/31315864PubMed
29939406Botulinum toxins for the prevention of migraine in adults.Cochrane Database Syst Rev2018https://conductscience.org/library/papers/29939406PubMed
28382110Botulinum toxin in the management of chronic migraine: clinical evidence and experience.Ther Adv Neurol Disord2017https://conductscience.org/library/papers/28382110PubMed
24819339Therapeutic use of botulinum toxin in migraine: mechanisms of action.Br J Pharmacol2014https://conductscience.org/library/papers/24819339PubMed
22331030Chronic migraine--classification, characteristics and treatment.Nat Rev Neurol2012https://conductscience.org/library/papers/22331030PubMed
22275844Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine.Neuropsychiatr Dis Treat2012https://conductscience.org/library/papers/22275844PubMed
20931348Are the current IHS guidelines for migraine drug trials being followed?J Headache Pain2010https://conductscience.org/library/papers/20931348PubMed
20159899Prophylaxis of migraine headache.CMAJ2010https://conductscience.org/library/papers/20159899PubMed
19750179The pharmacological management of migraine, part 2: preventative therapy.P T2008https://conductscience.org/library/papers/19750179PubMed
18095750Botulinum toxin for pain.Drugs R D2008https://conductscience.org/library/papers/18095750PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17547312

GET https://conductscience.org/api/papers/v1/17547312/authors